Literature DB >> 2967237

Effect of supplementary vaccination in healthy non-responders to hepatitis B vaccination.

P Wismans1, J van Hattum, T Stelling, J Poel, G C de Gast.   

Abstract

Among 831 healthy hospital employees vaccinated in accordance with a standard hepatitis B vaccination schedule (three doses of 20 micrograms i.m.), we found 38 (4.6%) hypo- and non-responders with an anti-HBs level less than 10 IU/l. Additional vaccinations with up to three standard doses of hepatitis B vaccine were given to 26 individuals, nine of whom developed anti-HBS titers higher than 10 IU/l after one additional vaccination. Two subjects received no further vaccination. The remaining group of 15 persons were given 2 more injections. After six vaccinations, nine subjects had an anti-HBs response of more than 10 IU/l, while six still had no detectable anti-HBs. In conclusion, supplementary vaccination of healthy hypo- and non-responders after standard hepatitis B vaccination induced an anti-HBs titer greater than 10 IU/l in 38% after one and in 75% after three additional doses of 20 micrograms of hepatitis B vaccine given intramuscularly.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2967237

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen.

Authors:  P J Wismans; J van Hattum; G C De Gast; H J Endeman; J Poel; B Stolk; T Maikoe; G C Mudde
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

2.  [Prevention of virus hepatitis A to E].

Authors:  M Cornberg; M P Manns
Journal:  Internist (Berl)       Date:  2011-03       Impact factor: 0.743

3.  Four-year follow up of hepatitis C patients vaccinated against hepatitis B virus.

Authors:  Slawomir Chlabicz; Tadeusz-Wojciech Lapinski; Anna Grzeszczuk; Danuta Prokopowicz
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

4.  Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders.

Authors:  Kunal Das; R K Gupta; V Kumar; P Kar
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

Review 5.  Is hemodialysis a reason for unresponsiveness to hepatitis B vaccine? Hepatitis B virus and dialysis therapy.

Authors:  Dede Sit; Bennur Esen; Ahmet Engin Atay; Hasan Kayabaşı
Journal:  World J Hepatol       Date:  2015-04-18

6.  Is a low dose of hepatitis B vaccine enough for a rapid vaccination scheme?

Authors:  Ru-Xiang Wang; Greet Boland; Ying Guo; Shao-Ping Lei; Chang-Hong Yang; Juan Chen; Jie Tian; Jin-Ying Wen; Ke-Hong Du; Jan van Hattum; Gijsbert C de Gast
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.